Peptide Reality Check

NAD+

Coenzyme (not a peptide) · B-tier (Dr. Alex Tatem) · Limited evidence

A coenzyme essential to cellular energy. Levels fall with age, so topping them up makes sense on paper. Proof of benefit from IV or injected NAD+ is thin.

Dr. Tatem’s take

B-tier: “as safe as any other compound that we’ve ever talked about”, with sound biology, though it “may not have a ton of placebo-controlled peer-reviewed data.”

In Dr. Tatem’s tier list

History & background

NAD (nicotinamide adenine dinucleotide) was discovered in 1906 by Arthur Harden and William Young as a “cozymase” needed for yeast fermentation; Harden and Hans von Euler-Chelpin shared the 1929 Nobel Prize in Chemistry partly for this work.

Interest in NAD+ for aging grew in the 2000s–2010s after research linked falling NAD+ levels to aging in animals, which fueled oral precursors (NR, NMN) and IV “drip” clinics. No IV NAD+ product is FDA-approved.

Benefits

Risks

Dosing protocols (informational, labeled by evidence)

Status: Not an FDA-approved drug for any use. IV infusions over 100 mL per 12 hours are banned in tested sport.

Grade and commentary: Dr. Alex Tatem. Watch: Truth About More Popular Peptides (What Works, What’s Overhyped) | Peptide Tier List pt.2, The Truth About NAD (From a Doctor). Subscribe: @DrAlexTatem.